The Study of the Use of Nintedanib in Slowing Lung Disease in Patients With Fibrotic or Non-Fibrotic Interstitial Lung Disease Related to COVID-19
Clinical trial NCT04619680 · COMPLETED
Trial details
- NCT number
- NCT04619680
- Sponsor
- Icahn School of Medicine at Mount Sinai
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2020-11-18
- Primary completion
- 2024-02-01
- Enrollment
- 103
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.